Complex relationship between blood pressure and mortality in type 2 diabetic patients -: A follow-up of the Botnia Study

被引:45
作者
Rönnback, M
Isomaa, B
Fagerudd, J
Forsblom, C
Groop, PH
Tuomi, T
Groop, L
机构
[1] Univ Helsinki, Folkhalsan Res Ctr, Biomedicum Helsinki C318B, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, Helsinki, Finland
[3] Lund Univ, Wallenberg Lab, Univ Hosp MAS, Dept Endocrinol, Malmo, Sweden
[4] Univ Helsinki, Res Program Mol Med, Helsinki, Finland
[5] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
[6] Malmska Municipal Hlth Care Ctr & Hosp, Pietarsaari, Finland
关键词
diabetes mellitus; blood pressure; cardiovascular diseases; elderly; mortality; risk factors;
D O I
10.1161/01.HYP.0000199667.30253.b7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The presence of hypertension aggravates the high cardiovascular risk in type 2 diabetic patients. Pulse pressure is a marker of arterial stiffness and constitutes a risk factor for cardiovascular mortality. This study examines the relationship between different blood pressure indices and mortality in a cohort of type 2 diabetic patients. A total of 1294 type 2 diabetic patients with a median age of 69.1 years participated in the Botnia Study from 1990 to 1997. In 2004, after a median follow-up of 9.5 years, data on mortality was collected from the national population registry and hospital records. Systolic and diastolic blood pressure correlated negatively with mortality after adjustment for other risk factors. The association between low systolic and diastolic blood pressure and mortality was pronounced in patients with previous cardiovascular disease. A U-shaped association between pulse pressure and mortality was observed in elderly patients. These observations could be linked to arterial stiffness and heart failure. Low blood pressure in high-risk patients is likely to be a marker of poor health rather than the cause of mortality. The results suggest that the role of blood pressure as a risk marker in elderly type 2 diabetic patients with cardiovascular disease needs to be reevaluated.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 31 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   Effects of blood pressure level on progression of diabetic nephropathy - Results from the RENAAL study [J].
Bakris, GL ;
Weir, MR ;
Shanifar, S ;
Zhang, ZX ;
Douglas, J ;
van Dijk, DJ ;
Brenner, BM .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (13) :1555-1565
[4]   Heart failure prevalence, incidence, and mortality in the elderly with diabetes [J].
Bertoni, AG ;
Hundley, WG ;
Massing, MW ;
Bonds, DE ;
Burke, GL ;
Goff, DC .
DIABETES CARE, 2004, 27 (03) :699-703
[5]   Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study [J].
Franklin, SS ;
Khan, SA ;
Wong, ND ;
Larson, MG ;
Levy, D .
CIRCULATION, 1999, 100 (04) :354-360
[6]   Metabolic consequences of a family history of NIDDM (The Botnia Study) - Evidence for sex-specific parental effects [J].
Groop, L ;
Forsblom, C ;
Lehtovirta, M ;
Tuomi, T ;
Karanko, S ;
Nissen, M ;
Ehrnstrom, BO ;
Forsen, B ;
Isomaa, B ;
Snickars, B ;
Taskinen, MR .
DIABETES, 1996, 45 (11) :1585-1593
[7]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[8]  
HAKALA SM, 1997, EUR HEART J, V18, P889
[9]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[10]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689